18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
It is hoped that in the not too distant future, noninvasive imaging-based molecular interrogation and characterization of tumors can improve our fundamental understanding of the dynamic biologic behavior of cancer. For example, the new dimension of diagnostic information that is provided by (18)F-FDG PET has led to improved clinical decision making and management changes in a substantial number of patients with cancer. In this context, the aim of this review is to bring together and summarize the current data on the correlation between the underlying molecular biology and the clinical observations of tumor (18)F-FDG accumulation in 3 major human cancers: lung, breast, and colon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
Macheda, M. L., Rogers, S., & Best, J. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20166 · Cited by 1,229
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function
Wilson, J. E. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00241 · Cited by 1,085
Glucose transporters: expression, regulation and cancer
MEDINA, R. A., & OWEN, G. I. (2002) · Biological Research · doi:10.4067/s0716-97602002000100004 · Cited by 472
Higashi, K., Ueda, Y., Sakurai, A., MingWang, X., Xu, L., Murakami, M., Seki, H., Oguchi, M., Taki, S., Nambu, Y., et al. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000367 · Cited by 210
Marom, E. M., Aloia, T. A., Moore, M.-B., Hara, M., Herndon, J. E., Harpole, D. H., Goodman, P. C., & Patz, E. F. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00250-6 · Cited by 69 · cited 1×
“66) between tumor SUV and GLUT1 overexpression has been reported by other studies (40–42); however, this has not been observed by some investigators (43) or has been shown to also be the case with benign conditions (e.”
Background
Cited by
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
A Systematic Review of the Factors Affecting Accuracy of SUV Measurements
Adams, M. C., Turkington, T. G., Wilson, J. M., & Wong, T. Z. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4923 · Cited by 662
Lactate metabolism: historical context, prior misinterpretations, and current understanding
Ferguson, B. S., Rogatzki, M. J., Goodwin, M. L., Kane, D. A., Rightmire, Z., & Gladden, L. B. (2018) · European Journal of Applied Physiology · doi:10.1007/s00421-017-3795-6 · Cited by 441
Role of monocarboxylate transporters in human cancers: state of the art
Pinheiro, C., Longatto-Filho, A., Azevedo-Silva, J., Casal, M., Schmitt, F. C., & Baltazar, F. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9428-1 · Cited by 368
“This widespread clinical application is used for diagnosis, initial staging, restaging, prediction, monitoring of treatment response and surveillance in a variety of cancers (Jadvar et al. 2009).”
MethodCancer‐generated lactic acid: a regulatory, immunosuppressive metabolite?
Choi, S. Y. C., Collins, C. C., Gout, P. W., & Wang, Y. (2013) · The Journal of Pathology · doi:10.1002/path.4218 · Cited by 338
Metadata
- Authors
- Jadvar, H., Alavi, A., & Gambhir, S. S.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2009-10-16
- Volume
- 50
- Issue
- 11
- Pages
- 1820-1827
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2066655532
- Cited by
- 227
- References
- 5
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.